Skip to main content
Clinical Trials/NCT04816708
NCT04816708
Completed
Not Applicable

A Self-directed Mobile Mindfulness Intervention to Address Distress and Burnout in Frontline Healthcare Workers

Duke University1 site in 1 country102 target enrollmentMay 19, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Emotional Distress
Sponsor
Duke University
Enrollment
102
Locations
1
Primary Endpoint
Sessions Completed
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This is a pilot randomized waitlist control trial assessing if the feasibility of using a mobile mindfulness app to treat emotional distress and burnout amongst nurses taking care of COVID-19 patients. This trial will help inform the study team if dissemination the intervention to a large number of nurses in a short time period is feasible, and if the intervention has evidence of a clinical impact.

Detailed Description

Emotional distress and burnout are common among health care workers, particularly among nurses. These burdens have been worsened due to the COVID-19 pandemic's imposition of substantial physical and psychological stressors as well as persistent worry about personal health. There are few effective therapies for healthcare workers' symptoms of distress, fewer still that can be easily scaled, and most require face-to-face contact which is discouraged during a pandemic. Mindfulness is a type of mind-body therapy that promotes a practice of non-judgmental awareness that can alleviate distress by uncoupling emotional reactions and habitual behavior from unpleasant symptoms, thoughts, and emotions. LIFT is a mobile mindfulness app which can assess levels of emotional distress via survey, and subsequently offer mindfulness content. The LIFT-Healthcare Worker pilot randomized control trial (RCT) seeks to address those unmet needs. The trial will explore the feasibility and impact of the LIFT mobile app in relieving symptoms of emotional distress among nurses directly caring for COVID-19 patients in the Duke University Health System. Target enrollment is for up to 200 participants. After signing consent, participants will be randomized via the LIFT app in a 2:1 (intervention:control) fashion into two arms: 1. Arm 1: Intervention group (access to LIFT mindfulness app) 2. Arm 2: Control waitlist group (delayed access to LIFT app) Aim 1, which is to determine the feasibility of using the LIFT app among nurses directly caring for COVID-19 patients, will be assessed via the app which tracks user fidelity and adherence, and the use of an interactive dashboard for administrative users (i.e., study team) to track individual participant use. An open ended narrative question at 1 month will also help provide guidance for improving usability in future studies, as will directed telephone interviews with participants with high and low app. Aim 2, which is to assess evidence of clinical impact of LIFT compared to control among nurses directly caring for COVID-19 patients at 1 month, will be assessed by comparing changes in the Patient Health Questionnaire-9 (PHQ-9), General Anxiety Disorder -7 (GAD-7) questionnaire, the Maslach Burnout Index (MBI), and Perceived Stress Scale 4 (PSS-4) over the study duration (1 month) between intervention and usual care groups.

Registry
clinicaltrials.gov
Start Date
May 19, 2021
End Date
February 4, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult ≥ 18 years of age
  • Currently working as a nurse in an adult COVID unit at Duke University Hospital
  • English Fluency

Exclusion Criteria

  • Lack of access to either reliable smartphone with cellular data plan or home internet access.
  • Anticipation of leaving current position in ≤30 days.

Outcomes

Primary Outcomes

Sessions Completed

Time Frame: 30 days post-randomization

Number of daily mindfulness sessions completed by participants in intervention arm, a measure of feasibility.

Intervention Completion

Time Frame: 30 days post randomization

The percentage of participants who complete all 4 weeks of the intervention, a measure of feasibility.

Survey Completion at Baseline

Time Frame: Baseline

The percentage of patients who complete surveys at baseline, a measure of feasibility.

Survey Completion at 1 Month

Time Frame: 30 days post randomization

The percentage of patients who complete surveys at 1 month, a measure of feasibility.

Secondary Outcomes

  • Change in Perceived Stress Scale (PSS-4)(Baseline to 30 days post-randomization)
  • Change in Maslach Burnout Index (MBI) - Emotional Exhaustion(Baseline to 30 days post-randomization)
  • Change in Patient Health Questionnaire-9 Item Scale (PHQ-9)(Baseline to 30 days post-randomization)
  • Change in Generalized Anxiety Disorder 7-item Scale (GAD-7)(Baseline to 30 days post-randomization)
  • Change in Maslach Burnout Index (MBI) - Depersonalization(Baseline to 30 days post-randomization)
  • Change in Maslach Burnout Index (MBI) - Personal Accomplishment(Baseline to 30 days post-randomization)

Study Sites (1)

Loading locations...

Similar Trials